Pfizer, BioNTech start clinical trial of Omicron-specific Covid-19 vaccine
Berlin : German biotechnology company BioNTech and US company Pfizer have started clinical trials of an Omicron-based Covid-19 vaccine candidate in healthy adults aged from 18 to 55 years, the companies have said.The trials would evaluate…